Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Hereditary Testing Market Expected To Reach $10.17 Billion By 2030 At 8.9% CAGR

The realm of hereditary testing has witnessed robust expansion recently, projecting an increase from $6.62 billion in 2025 to $7.23 billion in 2026, propelled by a compound annual growth rate of 9.2%. This historical growth trajectory is underpinned by several key factors, including groundbreaking progress in genetic sequencing technologies, heightened public consciousness regarding inherited conditions, the proliferation of clinical genetics programs, a downward trend in the cost of genetic testing, and the development of extensive diagnostic laboratory networks.

The hereditary testing sector is poised for substantial expansion over the forthcoming years, projected to reach $10.17 billion by 2030, exhibiting a compound annual growth rate of 8.9%. This anticipated upswing during the forecast period is largely fueled by the escalating integration of genomic insights into standard medical practices, a surge in the need for precision medicine solutions, a broader implementation of genetic screening across populations, the proliferating utilization of digital genetic data infrastructures, and a heightened emphasis on genomics for proactive health management. Key developments shaping this market during the forecast period encompass a greater embrace of next-generation sequencing technologies, a growing requirement for genetic testing that predicts disease risk or identifies carriers, the increased deployment of artificial intelligence for interpreting genetic variations, the augmentation of screening initiatives for prenatal and newborn diagnostics, and an intensified focus on providing tailored genetic advisory services.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25782&type=smp

Hereditary Testing Market Demand Drivers: What Is Fueling Industry Growth?

The expanding incidence of conditions influenced by genetics is poised to significantly boost the hereditary testing market. These genetic conditions stem from alterations or changes within a person’s DNA, passed down from parents or occurring randomly, and their growing frequency is partly attributed to older parental ages, which elevate the chances of such mutations affecting offspring. Hereditary tests are crucial for individuals with genetic disorders, facilitating prompt identification, tailored therapeutic approaches, and informed choices about family expansion by pinpointing inherited genetic variations. A relevant example showcases this trend: in October 2024, the Cystic Fibrosis Trust in the UK reported that the count of individuals diagnosed with cystic fibrosis reached 11,318 in 2023, an increase from the 11,148 cases recorded in 2022, underscoring the upward trajectory of genetic disorders and, consequently, fueling the expansion of the hereditary testing market.

Hereditary Testing Market Segment Analysis: What Are The Major Market Categories?

The hereditary testing market covered in this report is segmented –

1) By Test Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Testing, Other Test Types

2) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Buccal Swabs, Amniotic Fluid And Cord Blood Samples

3) By Technology Used: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Sanger Sequencing, Microarray Technology, Whole Genome Sequencing (WGS)

4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders, Other Applications

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Patients And Consumers

Subsegments:

1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing, Lynch Syndrome Testing, Familial Hypercholesterolemia Testing, Huntington’s Disease Testing, Cardiomyopathy Genetic Testing

2) By Carrier Testing: Cystic Fibrosis Carrier Screening, Tay-Sachs Carrier Screening, Spinal Muscular Atrophy (SMA) Carrier Screening, Thalassemia Carrier Screening, Sickle Cell Carrier Testing

3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Chorionic Villus Sampling (CVS), Amniocentesis, Expanded Carrier Screening (Prenatal Context), Cell-Free Fetal Deoxyribonucleic Acid Testing

4) By Newborn Screening: Phenylketonuria (PKU) Screening, Congenital Hypothyroidism Screening, Cystic Fibrosis Screening, Sickle Cell Disease Screening, Hearing Loss and Metabolic Disorder Panels

5) By Diagnostic Testing: Rare Disease Genetic Testing, Inherited Cancer Diagnostic Testing, Cardiogenetic Diagnostic Panels, Neurogenetic Disorder Testing, Monogenic Disease Panels

6) By Other Test Types: Pharmacogenomics Testing, Preimplantation Genetic Diagnosis (PGD), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), Mitochondrial Deoxyribonucleic Acid Testing

Hereditary Testing Market Innovation Trends: Which Developments Are Transforming The Industry?

Within the hereditary testing sector, leading firms are prioritizing the enhancement of genetic testing kits through technological innovation, aiming to elevate precision, accelerate processing periods, and broaden the scope of detectable genetic alterations. These kits function as analytical instruments for examining an individual’s DNA, thereby pinpointing genetic alterations or variances associated with inherited ailments or predispositions to disease. As an illustration, in July 2023, Devyser Diagnostics AB, a Swedish biotechnology entity involved in the creation, production, and marketing of DNA diagnostic kits for the examination of inherited diseases, introduced two novel targeted next-generation sequencing kits: Devyser LynchFAP and Devyser BRCA PALB2. The Devyser LynchFAP kit stands out by facilitating a comprehensive examination of PMS2, successfully navigating the complexities presented by its pseudogene PMS2CL, in addition to nine other crucial genes implicated in hereditary colorectal cancer syndromes. Complementing this, the Devyser BRCA PALB2 kit offers an integrated, single-tube methodology for the screening of mutations in BRCA1, BRCA2, and PALB2, applicable to both blood and tumor specimens. This kit is engineered for optimized laboratory procedures, delivering efficient, intuitive sequencing capabilities and specialized software to ensure reliable identification of hereditary cancer risks.

Hereditary Testing Market Leading Companies Driving Competitive Growth

Major companies operating in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.

Access The Complete Hereditary Testing Market Report:

https://www.thebusinessresearchcompany.com/report/hereditary-testing-global-market-report

Hereditary Testing Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the hereditary testing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model